Stockscreener 앱 받기
20.98
1.55%
-0.325
전일 마감가:
$21.30
열려 있는:
$21.16
하루 거래량:
37,340
Relative Volume:
0.19
시가총액:
$712.23M
수익:
-
순이익/손실:
$-81.05M
주가수익비율:
-7.996
EPS:
-2.6232
순현금흐름:
$-68.97M
1주 성능:
+0.24%
1개월 성능:
+27.71%
6개월 성능:
-34.43%
1년 성능:
+21.71%
1일 변동 폭
$20.66
$21.42
1주일 범위
$19.48
$21.79
52주 변동 폭
$15.47
$36.37
Arrivent Biopharma Inc Stock (AVBP) Company Profile
명칭
Arrivent Biopharma Inc
전화
240-780-6356
주소
18 CAMPUS BLVD., NEWTOWN SQUARE
AVBP을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
AVBP
Arrivent Biopharma Inc
|
20.97 | 712.23M | 0 | -81.05M | -68.97M | -2.6232 |
|
VRTX
Vertex Pharmaceuticals Inc
|
503.09 | 127.64B | 11.02B | -535.60M | -978.00M | -2.20 |
|
REGN
Regeneron Pharmaceuticals Inc
|
607.22 | 65.95B | 14.09B | 4.50B | 2.96B | 39.28 |
|
ARGX
Argen X Se Adr
|
655.28 | 37.92B | 2.19B | 833.04M | -1.28B | 12.71 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
271.20 | 32.98B | 2.25B | -278.16M | -42.59M | -2.17 |
|
ONC
Beigene Ltd Adr
|
254.91 | 26.89B | 3.81B | -644.79M | -669.77M | -6.24 |
Arrivent Biopharma Inc Stock (AVBP) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2025-03-20 | 개시 | B. Riley Securities | Buy |
| 2025-03-10 | 개시 | Guggenheim | Buy |
| 2024-07-22 | 개시 | Oppenheimer | Outperform |
| 2024-04-30 | 개시 | H.C. Wainwright | Buy |
| 2024-02-20 | 개시 | Citigroup | Buy |
| 2024-02-20 | 개시 | Goldman | Buy |
| 2024-02-20 | 개시 | Jefferies | Buy |
모두보기
Arrivent Biopharma Inc 주식(AVBP)의 최신 뉴스
ArriVent BioPharma, Inc. (NASDAQ:AVBP) Shares Acquired by Wells Fargo & Company MN - Defense World
ArriVent BioPharma (NASDAQ:AVBP) Shares Gap Down – Here’s Why - Defense World
Barclays PLC Grows Holdings in ArriVent BioPharma, Inc. (NASDAQ:AVBP) - Defense World
Invesco Ltd. Takes Position in ArriVent BioPharma, Inc. (NASDAQ:AVBP) - Defense World
ArriVent BioPharma, Inc. (NASDAQ:AVBP) Shares Acquired by JPMorgan Chase & Co. - Defense World
ArriVent BioPharma, Inc. (NASDAQ:AVBP) Short Interest Update - Defense World
Legal & General Group Plc Purchases 10,783 Shares of ArriVent BioPharma, Inc. (NASDAQ:AVBP) - Defense World
ArriVent BioPharma Appoints Dr. Merdad Parsey to Board of Directors - MyChesCo
Ardelyx Appoints Merdad Parsey, M.D., Ph.D. to its Board of Directors - The Manila Times
ArriVent BioPharma appoints new board member By Investing.com - Investing.com South Africa
ArriVent BioPharma appoints new board member - Investing.com Australia
ArriVent BioPharma Appoints Merdad Parsey, M.D., Ph.D. to its Board of Directors - citybiz
ArriVent BioPharma (AVBP) Strengthens Leadership with New Board Appointment | AVBP Stock News - GuruFocus
Arbutus Biopharma Showcases Promising Hepatitis B Research at EASL Congress - MyChesCo
Learn to Evaluate (AVBP) using the Charts - news.stocktradersdaily.com
Geode Capital Management LLC Cuts Stake in ArriVent BioPharma, Inc. (NASDAQ:AVBP) - Defense World
In Depth: Popular Overseas Expansion Strategy Holds Pitfalls for Chinese Drug Developers - Caixin Global
Vanguard Group Inc. Has $37.76 Million Stock Holdings in ArriVent BioPharma, Inc. (NASDAQ:AVBP) - Defense World
41,921 Shares in ArriVent BioPharma, Inc. (NASDAQ:AVBP) Bought by Wellington Management Group LLP - Defense World
ArriVent BioPharma, Inc. (NASDAQ:AVBP) Given Average Recommendation of “Buy” by Brokerages - Defense World
KLP Kapitalforvaltning AS Purchases New Shares in ArriVent BioPharma, Inc. (NASDAQ:AVBP) - Defense World
Corebridge Financial Inc. Has $373,000 Stake in ArriVent BioPharma, Inc. (NASDAQ:AVBP) - Defense World
(AVBP) Trading Report - news.stocktradersdaily.com
Swiss National Bank Buys Shares of 26,400 ArriVent BioPharma, Inc. (NASDAQ:AVBP) - Defense World
Arbutus Biopharma Reports 2024 Financial Results and Strategic Updates - MyChesCo
Aprea Therapeutics Reports 2024 Financial Results and Updates on Clinical Innovations - MyChesCo
Charles Schwab Investment Management Inc. Has $5.50 Million Stake in ArriVent BioPharma, Inc. (NASDAQ:AVBP) - Defense World
ArriVent BioPharma (AVBP) Projected to Post Earnings on Thursday - The AM Reporter
Brokers Offer Predictions for AVBP Q1 Earnings - Defense World
Brokerages Set ArriVent BioPharma, Inc. (NASDAQ:AVBP) Target Price at $39.40 - Defense World
B. Riley Begins Coverage on ArriVent BioPharma (NASDAQ:AVBP) - Defense World
ArriVent BioPharma (NASDAQ:AVBP) Upgraded at B. Riley - Defense World
B.Riley sets $37 target on ArriVent stock, initiates with Buy - Investing.com Canada
ArriVent Lead Drug Candidate Shows Promise In Lung Cancer Type, Analyst Sees Over 50% Upside - Benzinga
This Microsoft Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Thursday - Benzinga
B. Riley Initiates ArriVent BioPharma at Buy With $37 Price Target -March 20, 2025 at 07:13 am EDT - MarketScreener
ArriVent Biopharma initiated with a Buy at B. Riley - TipRanks
ArriVent BioPharma (AVBP) Projected to Post Quarterly Earnings on Thursday - Defense World
ArriVent BioPharma (AVBP): Among the Best Short Squeeze Stocks to Buy According to Analysts - Insider Monkey
10 Best Short Squeeze Stocks to Buy According to Analysts - Insider Monkey
ArriVent BioPharma reports FY results - MSN
Taiho Expands Cancer Pipeline With ADCs In $400m Araris Buy - insights.citeline.com
(AVBP) Technical Pivots with Risk Controls - news.stocktradersdaily.com
ArriVent BioPharma appoints PwC as new auditor - Investing.com India
ArriVent BioPharma appoints PwC as new auditor By Investing.com - Investing.com South Africa
ArriVent BioPharma (NASDAQ:AVBP) Now Covered by Analysts at Guggenheim - Defense World
Oppenheimer starts ArriVent BioPharma at outperform - MSN
Guggenheim starts ArriVent Biopharma with a Buy on firmonertinib potential - TipRanks
Financial Contrast: ArriVent BioPharma (AVBP) and The Competition - Defense World
ArriVent BioPharma (NASDAQ:AVBP) Earns “Buy” Rating from HC Wainwright - Defense World
Here's What Could Help ArriVent BioPharma, Inc. (AVBP) Maintain Its Recent Price Strength - MSN
Arrivent Biopharma Inc (AVBP) 재무 분석
매출
순이익
현금흐름
주당 순 이익
0.27%
0.30%
자본화:
|
볼륨(24시간):